TP53 and malignant colon neoplasm: Based on the analysis of cell lines in which AKG exhibited anti-cancer activity [19,20,21,22], we identified that all these cell lines, except the LS-180 colon cancer cell line, have TP53 mutations; nevertheless, AKG also inhibited the proliferation of LS-180 cells with the wild type of p53.